Why 2017 Was a Year to Remember for Exact Sciences Corporation
Any year that a stock goes up 40% would count as a memorable year. But what about a year where a stock soars nearly 340%? That's what has happened for Exact Sciences Corporation (NASDAQ: EXAS) in 2017 -- and there are still a few weeks left to go in the year.
To say that 2017 will be a year to remember for Exact Sciences is an understatement. Here's how the molecular diagnostics company achieved its tremendous success and whether that success is likely to continue into 2018.
Image source: Getty Images.
Source: Fool.com
Exact Sciences Aktie
60,89 €
3,06 %
Die Exact Sciences Aktie steht gut da mit mehreren Buy- und keiner Sell-Einschätzung.
Für Exact Sciences ergibt sich mit einem Kursziel von 76 € eine mögliche Steigerung von über 20% gegenüber 60.89 €.
